Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

15 trials with published results (8%)

Research Maturity

121 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.1%

10 terminated out of 196 trials

Success Rate

92.4%

+5.9% vs benchmark

Late-Stage Pipeline

33%

64 trials in Phase 3/4

Results Transparency

12%

15 of 121 completed with results

Key Signals

15 with results92% success

Data Visualizations

Phase Distribution

163Total
Not Applicable (75)
Early P 1 (2)
P 1 (10)
P 2 (12)
P 3 (29)
P 4 (35)

Trial Status

Completed121
Unknown32
Recruiting17
Terminated10
Not Yet Recruiting8
Withdrawn5

Trial Success Rate

92.4%

Benchmark: 86.5%

Based on 121 completed trials

Clinical Trials (196)

Showing 20 of 20 trials
NCT07510984Recruiting

Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)

NCT01696734Phase 3Recruiting

Domperidone in Treating Patients With Gastrointestinal Disorders

NCT07458490Not Yet Recruiting

Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound

NCT07010744Not ApplicableEnrolling By InvitationPrimary

Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection

NCT04918329Recruiting

Functional Digestive Disorders Observatory

NCT06760897Not ApplicableCompletedPrimary

Effect of Gastrogenic Microbiota in FD

NCT07272681Not Yet Recruiting

Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms

NCT07261228Recruiting

The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding

NCT07139366Phase 4Recruiting

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

NCT06150638Not ApplicableCompleted

Treatment of Functional Abdominal Distension by Non-instrumental Biofeedback

NCT06369753Not ApplicableRecruiting

Visible Abdominal Distension

NCT03603730Not ApplicableRecruitingPrimary

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

NCT05587127Not ApplicableRecruiting

Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia

NCT06909890Not ApplicableRecruitingPrimary

A Study of Chios Mastic Water in Dyspepsia

NCT06941545Not ApplicableRecruitingPrimary

High Resolution Gastric Mapping and Gastroduodenal Manometry

NCT06756503Not Yet Recruiting

Exocrine Pancreatic Insufficiency and Functional Dyspepsia

NCT05553587Phase 4CompletedPrimary

Symptoms and Physiological Effects of Amara in Functional Dyspepsia

NCT05742568Phase 4Completed

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

NCT07028671CompletedPrimary

Exploratory Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms

NCT06755671Recruiting

A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms

Scroll to load more

Research Network

Activity Timeline